Anaplastic thyroid cancer is a rare disease, accounting for just 1.6% of all thyroid cancers. It is the most lethal among all thyroid cancers, with a median life expectancy of about 5 months.

CHICAGO — In patients with stage IVB anaplastic thyroid cancer, the inclusion of adjuvant pembrolizumab to conventional multimodal therapy shows significant benefits in reducing the recurrence ...

In patients with metastatic anaplastic thyroid cancer who have progressed on chemotherapy — who have a poor prognosis —a new combination of nonchemotherapy drugs shows promise. The combination ...

Overall survival rates for adults diagnosed with anaplastic thyroid carcinoma are similar between those with a history of cancer and those with no previous cancer diagnosis, according to findings ...

Anaplastic thyroid cancer (ATC) is a rare and aggressive form of cancer affecting the thyroid. Doctors usually treat it with surgery as well as chemotherapy and radiation. There are four types of ...

Source Reference: Cabanillas ME, et al "Anti-programmed death ligand 1 plus targeted therapy in anaplastic thyroid carcinoma: A nonrandomized clinical trial" JAMA Oncol 2024; DOI: 10.1001 ...

DelveInsight's, “Anaplastic Thyroid Cancer Pipeline Insight 2025,” report provides comprehensive insights about 8+ companies and 8+ pipeline drugs in Anaplastic Thyroid Cancer pipeline landscape.

PURPOSE Anaplastic thyroid carcinoma is an aggressive malignancy that is almost always fatal and lacks effective systemic treatment options for patients with BRAF-wild type disease. As part of a phase ...

Staging for thyroid cancer generally follows the TNM staging system. This is made up of classifications about the tumor (T), the lymph nodes (N), and whether the cancer has metastasized (M).

The thyroid plays an important role in producing hormones to regulate the body. Evidence suggests that in 2021, there are roughly 44,280 new cases of thyroid cancer, with 12,150 cases occurring in ...

Two prospective trials of immunotherapy in thyroid cancer, one of them negative, provided support for precision-medicine approaches that include immunotherapy. A trial of atezolizumab (Tecentriq ...